Status: Recruiting
A Study of ATB1651 in Adults With Mild to Moderate Onchomycosis
The study is designed to evaluate the Safety, Tolerability and Pharmacokinetics of ATB1651 in participants with mild to moderate onychomycosis
Participants needed: 120
Trial details
Phase: Phase 2Age: 18-70Biological sex: AllType: InterventionalSponsor: AmtixBio Co., Ltd.Updated: Feb 19, 2025Locations: 1
Eligibility criteria
Confirmation of onychomycosis by positive mycological (KOH) staining and positiv... [+5]
History of allergy to any of the excipients in ATB1651. [+5]